selected scholarly activity
-
conferences
- Impact of Pelvic Intensity-modulated Radiotherapy (IMRT) on Lymph Node Coverage and Dose to Critical Organs, Compare to Three-Dimensional Conformal Radiation Therapy (3D-CRT), in Localized High-Risk Prostate Cancer. International Journal of Radiation Oncology Biology Physics. e250-e250. 2020
- IMPACT OF PELVIC INTENSITY-MODULATED RADIOTHERAPY (IMRT) ON LYMPH NODE COVERAGE AND DOSE TO CRITICAL ORGANS, COMPARE TO THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT), IN LOCALIZED HIGH-RISK PROSTATE CANCER. Radiotherapy and Oncology. S68-S68. 2019
- Randomized Study of Quality of Life in Patients with High-Risk Prostate Cancer Undergoing Radiotherapy: Role of Pelvic Nodal IMRT. International Journal of Radiation Oncology Biology Physics. E211-E212. 2017
- Magnetic Resonance Imaging Measures of Disease Activity in Rheumatoid Arthritis Patients Treated with Multiple Regimens of DMARD Therapy. Journal of Rheumatology. 885-886. 2017
- NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA.. Journal of Clinical Oncology. 3-3. 2016
- Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA. International Journal of Radiation Oncology Biology Physics. 3-3. 2016
- Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer. International Journal of Radiation Oncology Biology Physics. S199-S200. 2015
- A randomized trial of 79.2Gy versus 70.2Gy radiation therapy (RT) for localized prostate cancer.. Journal of Clinical Oncology. 4-4. 2015
- Initial Results of a Phase 3 Randomized Study of High Dose 3DCRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (RTOG 0126). International Journal of Radiation Oncology Biology Physics. 1263-1263. 2014
- A Prospective Comparative Analysis of 3 Methods of Rectal Retraction for High-Dose-Rate Brachytherapy in Cervical Carcinoma: Effect on Organs at Risk. International Journal of Radiation Oncology Biology Physics. S476-S477. 2014
- A Retrospective Review of Patient Outcomes Following High-Dose-Rate Brachytherapy in the Treatment of Cervical Cancer. International Journal of Radiation Oncology Biology Physics. S489-S490. 2014
- Stereotactic Ablative Radiation Therapy for Gynecological Malignancies in the Oligometastatic Setting. International Journal of Radiation Oncology Biology Physics. S908-S908. 2014
- 536 oral RTOG 9601: SALVAGE RT & ANTI-ANDROGEN THERAPY IN PROSTATE CANCER PATIENTS WITH ELEVATED PSA AFTER SURGERY. Radiotherapy and Oncology. S219-S219. 2011
- Initial report of RTOG 9601, a phase III trial in prostate cancer: Effect of anti-androgen therapy (AAT) with bicalutamide during and after radiation therapy (RT) on freedom from progression and incidence of metastatic disease in patients following radical prostatectomy (RP) with pT2-3,N0 disease and elevated PSA levels. Journal of Clinical Oncology. 2011
- Initial Report of RTOG 9601: A Phase III Trial in Prostate Cancer: Anti-androgen Therapy (AAT) with Bicalutamide during and after Radiation Therapy (RT) Improves Freedom from Progression and Reduces the Incidence of Metastatic Disease in Patients following Radical Prostatectomy (RP) with pT2-3, N0 Disease, and Elevated PSA Levels. International Journal of Radiation Oncology Biology Physics. S27-S27. 2010
- ACUTE URINARY MORBIDITY OF RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER: DO PATIENTS UNDERGOING CONFORMAL RADIATION THERAPY WITH IMPLANTED GOLD SEEDS HAVE MORE URINARY SYMPTOMS DURING RADIATION THERAPY?. Radiotherapy and Oncology. S52-S53. 2008
- IMPACT OF BLADDER FILLING (FULL OR EMPTY) ON DOSE VOLUME HISTOGRAMS IN RADIATION PLANNING FOR POST-PROSTATECTOMY PATIENTS. Radiotherapy and Oncology. S54-S54. 2008
- INFLUENCE OF GOLD SEED IMPLANTATION ON DEFINING TARGET VOLUMES FOR CONFORMAL RADIOTHERAPY OF PROSTATE CANCER. Radiotherapy and Oncology. S51-S51. 2008
- Influence of Gold Seed Implantation on Defining Target Volumes for Conformal Radiotherapy of Prostate Cancer. International Journal of Radiation Oncology Biology Physics. S322-S322. 2008
- CT imaging in cervical cancer: Determination of dose delivered to bladder and rectum during intracavitary brachytherapy. Radiotherapy and Oncology. S17-S17. 2007
-
journal articles
- Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126. International Journal of Radiation Oncology Biology Physics. 112:83-92. 2022
- 158 Impact of Pelvic Intensity-Modulated Radiotherapy (IMRT) on Lymph Node Coverage and Dose to Critical Organs, Compare to Three-Dimensional Conformal Radiation Therapy (3D-CRT), in Localized High-Risk Prostate Cancer. Radiotherapy and Oncology. 139:S68-S68. 2019
- Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer. Cureus. 10:e3387. 2018
- Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer. JAMA Oncology. 4:e180039-e180039. 2018
- Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer. New England Journal of Medicine. 376:417-428. 2017
- Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01. Urologic Oncology: Seminars and Original Investigations. 34:430.e1-430.e7. 2016
- Prospective comparison of rectal dose reduction during intracavitary brachytherapy for cervical cancer using three rectal retraction techniques. Brachytherapy. 15:450-455. 2016
- Preliminary patient‐reported outcomes analysis of 3‐dimensional radiation therapy versus intensity‐modulated radiation therapy on the high‐dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial. Cancer. 121:2422-2430. 2015
- Brachytherapy Teaching Clinic. Journal of Medical Imaging and Radiation Sciences. 46:S22-S22. 2015
- Initial report of RTOG 9601, a phase III trial in prostate cancer: Effect of anti-androgen therapy (AAT) with bicalutamide during and after radiation therapy (RT) on freedom from progression and incidence of metastatic disease in patients following radical prostatectomy (RP) with pT2-3,N0 disease and elevated PSA levels.. Journal of Clinical Oncology. 29:1-1. 2011
- A Systematic Review and Meta-Analysis of Oncologic Outcomes of Pre- Versus Postoperative Radiation in Localized Resectable Soft-Tissue Sarcoma. Annals of Surgical Oncology. 17:1367-1374. 2010
- The design and dosimety of a four-channel cylinder for treatment of endometrial cancer with high-dose-rate brachytherapy using the varisource afterloader. Brachytherapy. 8:154-155. 2009
- Poster - Thurs Eve-38: CT Imaging in high dose rate brachytherapy for treatment of cervical cancer: Estimation of dose to bowel. Medical Physics. 35:3408-3408. 2008
- Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer. Gynecologic Oncology. 108:317-325. 2008
- Cross-Border Referral for Early Breast Cancer: An Analysis of Radiation Fractionation Patterns. Current Oncology. 13:124-129. 2006
- Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Clinical Respiratory Journal. 2015:CD001419. 2000
- A randomized trial comparing combination of iridium implant and external beam radiation vs. external beam radiation alone in node negative locally advanced cancer of the prostate: Preliminary report. International Journal of Radiation Oncology Biology Physics. 42:302-302. 1998
- Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. The Lancet. 350:1647-1654. 1997
- Breast irradiation postlumpectomy: development and evaluation of a decision instrument.. Journal of Clinical Oncology. 13:847-853. 1995